New Tack for Neurodegenerative Disease Research
Armed with New Tools and Lower Cost Sequencing, Researchers Take an Omics Approach to Neuro Diseases
Innovations in Viral Clearance
Mock Viruses, Plant Design, and Rational Testing
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
Ashok D. Bandaranayake Ph.D.
Ashok D. Bandaranayake, Ph.D., is from the Fred Hutch Cancer Center.
More GEN Content From This Contributor
- Sponsored Content: Application Note: Accelerating the Antibody Discovery Process